Literature DB >> 30639642

Autoimmunity in celiac disease: Extra-intestinal manifestations.

Lerner Aaron1, Matthias Torsten2, Wusterhausen Patricia2.   

Abstract

Celiac disease is an autoimmune condition of the small intestine caused by prolamins in genetically susceptible individuals evoked by multiple environmental factors. The pathological luminal intricate eco-events produce multiple signals that irradiate the entire body, resulting in a plethora of extra-intestinal manifestations. Nutrients, dysbiosis, dysbiotic components and their mobilome, post-translational modification of naive proteins, inter-enterocyte's tight junction dysfunction resulting in a leaky gut, microbial lateral genetic transfer of virulent genes, the sensing network of the enteric nervous systems and the ensuing pro-inflammatory messengers are mutually orchestrating the autoimmune interplay. Genetic-environmental-luminal events-mucosal changes are driving centrifugally the remote organs autoimmunity, establishing extra-intestinal multi organ injury. Exploring the underlying intestinal eco-events, the sensing and the delivery pathways and mechanisms that induce the peripheral tissues' damages might unravel new therapeutical strategies to prevent and help the gluten affected patients.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune; Autoimmunity; Celiac disease; Extra intestinal; Gliadin; Gluten

Mesh:

Year:  2019        PMID: 30639642     DOI: 10.1016/j.autrev.2018.09.010

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  13 in total

1.  Effect of canola proteins on rice flour bread and mathematical modelling of the baking process.

Authors:  Kamela Salah; Egor A Olkhovatov; Mohammed Aïder
Journal:  J Food Sci Technol       Date:  2019-06-11       Impact factor: 2.701

2.  Cross-Reactivity and Sequence Homology Between Alpha-Synuclein and Food Products: A Step Further for Parkinson's Disease Synucleinopathy.

Authors:  Aristo Vojdani; Aaron Lerner; Elroy Vojdani
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

Review 3.  Checkpoint Inhibitors and Induction of Celiac Disease-like Condition.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Biomedicines       Date:  2022-03-04

Review 4.  Navigating the Gluten-Free Boom: The Dark Side of Gluten Free Diet.

Authors:  Aaron Lerner; Thomas O'Bryan; Torsten Matthias
Journal:  Front Pediatr       Date:  2019-10-15       Impact factor: 3.418

Review 5.  Gut-brain Axis and migraine headache: a comprehensive review.

Authors:  Mahsa Arzani; Soodeh Razeghi Jahromi; Zeinab Ghorbani; Fahimeh Vahabizad; Paolo Martelletti; Amir Ghaemi; Simona Sacco; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-13       Impact factor: 7.277

6.  Seroprevalence of Antitransglutaminase and Antiendomysium Antibodies in Adult Colombian Blood Bank Donors.

Authors:  Sara Paredes-Echeverri; Ayda N Rodríguez; Wilmer A Cárdenas; Belén Mendoza de Molano; John M González
Journal:  Can J Gastroenterol Hepatol       Date:  2020-11-30

7.  In Vitro Studies Toward the Use of Chitin as Nutraceutical: Impact on the Intestinal Epithelium, Macrophages, and Microbiota.

Authors:  Liyou Dong; Renata M C Ariëns; Monic M Tomassen; Harry J Wichers; Coen Govers
Journal:  Mol Nutr Food Res       Date:  2020-10-16       Impact factor: 5.914

8.  Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.

Authors:  Aaron Lerner; Polina Sobolevskaia; Leonid Churilov; Yehuda Shoenfeld
Journal:  J Transl Autoimmun       Date:  2021-06-16

Review 9.  Gluten and FODMAPs Relationship with Mental Disorders: Systematic Review.

Authors:  Egoitz Aranburu; Silvia Matias; Edurne Simón; Idoia Larretxi; Olaia Martínez; María Ángeles Bustamante; María Del Pilar Fernández-Gil; Jonatan Miranda
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

Review 10.  Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.

Authors:  Mahesh Mohan; Chioma M Okeoma; Karol Sestak
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.